Rivastigmine | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Rivastigmine
Canada

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Rivastigmine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

27 API Suppliers, 13 USDMF, 8 CEP/COS, 6 JDMF, 6 EU WC, 18 KDMF, 5 NDC API, 16 Listed Suppliers, $ API Reference Price

27 API Suppliers
13 USDMF
8 CEP/COS
6 JDMF
6 EU WC
18 KDMF
5 NDC API
16 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

16 Drugs in Development

16 Drugs in Development

INTERMEDIATES

9 Intermediate Suppliers

9 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

353 FDF Dossiers, 18 FDA Orange Book, 269 Europe, 7 Canada, 14 Australia, 4 South Africa, 41 Listed Dossiers

353 FDF Dossiers
18 FDA Orange Book
269 Europe
7 Canada
14 Australia
4 South Africa
41 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 DKSH, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Gangwal Chemicals, 1 Sigachi Industries

1 DKSH
1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
1 Gangwal Chemicals
1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

2 Emulsifying Agents, 2 Lubricants & Glidants, 1 Thickeners and Stabilizers, 1 Direct Compression, 1 API Stability Enhancers, 1 Fillers, Diluents & Binders

2 Emulsifying Agents
2 Lubricants & Glidants
1 Thickeners and Stabilizers
1 Direct Compression
1 API Stability Enhancers
1 Fillers, Diluents & Binders

DIGITAL CONTENT

11 NEWS #PharmaBuzz

11 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 245 Finished Drug Prices, 10 Annual Reports

3 US Medicaid Prescriptions
245 Finished Drug Prices
10 Annual Reports

MARKET PLACE

8 APIs, 1 FDF Dossiers

8 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 Health Canada Patents

6 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 5 USP, 11 Others

3 EDQM
5 USP
11 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 3,351 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

7 All

01 3KNIGHT THERAPEUTICS INC.

02 2MYLAN PHARMACEUTICALS ULC

03 2SANDOZ CANADA INCORPORATED

filter Active Ingredients Reset all filters

7 All

01 7RIVASTIGMINE

filter Dosage Form Reset all filters

7 All

01 7PATCH

filter Brand Name Reset all filters

7 All

01 1EXELON PATCH 10

02 1EXELON PATCH 15

03 1EXELON PATCH 5

04 1MYLAN-RIVASTIGMINE PATCH 10

05 1MYLAN-RIVASTIGMINE PATCH 5

06 1SANDOZ RIVASTIGMINE PATCH 10

07 1SANDOZ RIVASTIGMINE PATCH 5

List of Suppliers

Product Main Page

01

KNIGHT THERAPEUTICS INC.

PharmScience R&D

Not Confirmed

KNIGHT THERAPEUTICS INC.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

RIVASTIGMINE

Brand Name : EXELON PATCH 5

Dosage Form : PATCH

Dosage Strength : 4.6MG/24HOUR

Packaging : 30

Approval Date :

Application Number : 2302845

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

KNIGHT THERAPEUTICS INC.

PharmScience R&D

Not Confirmed

KNIGHT THERAPEUTICS INC.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

RIVASTIGMINE

Brand Name : EXELON PATCH 10

Dosage Form : PATCH

Dosage Strength : 9.5MG/24HOUR

Packaging : 30

Approval Date :

Application Number : 2302853

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

KNIGHT THERAPEUTICS INC.

BioAsia

Not Confirmed

KNIGHT THERAPEUTICS INC.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

RIVASTIGMINE

Brand Name : EXELON PATCH 15

Dosage Form : PATCH

Dosage Strength : 13.3MG/24HOUR

Packaging : 30

Approval Date :

Application Number : 2432803

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

SANDOZ CANADA INCORPORATED

The Generic Rx Session

Not Confirmed

SANDOZ CANADA INCORPORATED

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

RIVASTIGMINE

Brand Name : SANDOZ RIVASTIGMINE PATCH 10

Dosage Form : PATCH

Dosage Strength : 9.5MG/24HOUR

Packaging : 30

Approval Date :

Application Number : 2426307

Regulatory Info :

Registration Country : Canada

Product Web Link

Digital Content

05

SANDOZ CANADA INCORPORATED

PharmScience R&D

Not Confirmed

SANDOZ CANADA INCORPORATED

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

RIVASTIGMINE

Brand Name : SANDOZ RIVASTIGMINE PATCH 5

Dosage Form : PATCH

Dosage Strength : 4.6MG/24HOUR

Packaging : 30

Approval Date :

Application Number : 2426293

Regulatory Info :

Registration Country : Canada

Product Web Link

Digital Content

06

MYLAN PHARMACEUTICALS ULC

PharmScience R&D

Not Confirmed

MYLAN PHARMACEUTICALS ULC

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

RIVASTIGMINE

Brand Name : MYLAN-RIVASTIGMINE PATCH 5

Dosage Form : PATCH

Dosage Strength : 4.6MG/24HOUR

Packaging : 30

Approval Date :

Application Number : 2423413

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

MYLAN PHARMACEUTICALS ULC

PharmScience R&D

Not Confirmed

MYLAN PHARMACEUTICALS ULC

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

RIVASTIGMINE

Brand Name : MYLAN-RIVASTIGMINE PATCH 10

Dosage Form : PATCH

Dosage Strength : 9.5MG/24HOUR

Packaging : 30

Approval Date :

Application Number : 2423421

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!